Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial
| Image |  |
|---|---|
| Description | scientific article published on 16 July 2019 |
| Author/s |
author: Florence Nguyen-Khac Alain Delmer Anne-Sophie Michallet |
| Publication date | July 16, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |